Researcher.Life Logo

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis : Impact Factor & More

eISSN: 1744-2818pISSN: 1350-6129

Key Metrics

CiteScore
8.7
H-Index
69
SJR
Q1Internal Medicine
SNIP
1.99
Recommended pre-submission checks
Powered by Paperpal by Editage

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis Journal Specifications

Indexed in the following public directories

  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment
  • 25 Jun 2026
  • Amyloid
Fat aspiration for amyloidosis screening of 2830 patients from 2013 to 2020: compelling sensitivity for AL and better sensitivity in females for all major subtypes
  • 25 Jun 2026
  • Amyloid
Exploring light chain cardiotoxicity in AL amyloidosis: impact on hiPSC-derived cardiomyocyte activity
  • 18 Jun 2026
  • Amyloid
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension
  • 15 Jun 2026
  • Amyloid
Fluorine-18 florbetapir positron emission tomography unmasks amyloidosis with equivocal technetium-99m pyrophosphate findings driven by a novel transthyretin variant.
  • 12 Jun 2026
  • Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Assessing hemorrhagic risk in transthyretin cardiac amyloidosis. The haemorrhagic–embolic conundrum
  • 6 Jun 2026
  • Amyloid
Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment
  • 25 Jun 2026
  • Amyloid
Fat aspiration for amyloidosis screening of 2830 patients from 2013 to 2020: compelling sensitivity for AL and better sensitivity in females for all major subtypes
  • 25 Jun 2026
  • Amyloid
Exploring light chain cardiotoxicity in AL amyloidosis: impact on hiPSC-derived cardiomyocyte activity
  • 18 Jun 2026
  • Amyloid
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension
  • 15 Jun 2026
  • Amyloid
Fluorine-18 florbetapir positron emission tomography unmasks amyloidosis with equivocal technetium-99m pyrophosphate findings driven by a novel transthyretin variant.
  • 12 Jun 2026
  • Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Assessing hemorrhagic risk in transthyretin cardiac amyloidosis. The haemorrhagic–embolic conundrum
  • 6 Jun 2026
  • Amyloid

FAQs on Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis